OXT and obesity due to melanocortin 4 receptor deficiency: Contrary to several negative results [281,282], intranasal oxytocin treatment reduced the consumption of sweet foods [283,284], total caloric intake [285], reward-driven food intake [286], and food cravings [287] in humans, particularly in persons with obesity [288,289].